These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2411161)

  • 21. [Granulocyte collection by intermittent flow centrifugation leukapheresis (IFC) and filtration leukapheresis (FL). Effects of high molecular hes and hydrocortisone on donors].
    Suenaga T; Odaka K; Shiobara S; Sachimichi H; Mori T
    Rinsho Ketsueki; 1981 Oct; 22(10):1667-71. PubMed ID: 6174752
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
    Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
    Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
    Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Topic on the theme "volume replacement". 6% HES 130/0.4 is the optimum combination].
    Diwo SB
    Anaesthesist; 1998 Sep; 47(9):815. PubMed ID: 9867721
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass.
    Sade RM; Crawford FA; Dearing JP; Stroud M
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):35-8. PubMed ID: 6177973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock.
    Armistead CW; Vincent JL; Preiser JC; De Backer D; Thuc Le Minh
    Anesth Analg; 1989 Dec; 69(6):714-20. PubMed ID: 2480072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].
    Prien T; Thülig B; Wüsten R; Schoofs J; Weyand M; Lawin P
    Zentralbl Chir; 1993; 118(5):257-63; discussion 264-6. PubMed ID: 7686707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary excretion of hydroxyethyl starch in man.
    Kalhorn TF; Yacobi A; Sum CY
    Biomed Mass Spectrom; 1984 Apr; 11(4):164-6. PubMed ID: 6203566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
    London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
    J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
    Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
    Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of high molecular weight hydroxyethylstarch in rats.
    Hulse JD; Stoll RG; Yacobi A; Gupta SD; Lai CM
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):149-58. PubMed ID: 6157182
    [No Abstract]   [Full Text] [Related]  

  • 35. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Colloidal hypertonic solutions in cardiac surgery].
    Boldt J; Hammermann H; Hempelmann G
    Zentralbl Chir; 1993; 118(5):250-6. PubMed ID: 7686706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution.
    Haas T; Fries D; Holz C; Innerhofer P; Streif W; Klingler A; Hanke A; Velik-Salchner C
    Anesth Analg; 2008 Apr; 106(4):1078-86, table of contents. PubMed ID: 18349176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
    de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
    Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.